Skip to main navigation

Immunocore

Primary Menu

Overview
News & Events
Stock Information
- Stock Quote & Chart
- Analysts Coverage
Corporate Governance
Financials & Filings
- SEC Filings
IR Resources

Primary Menu

Overview
News & Events
Stock Information
- Stock Quote & Chart
- Analysts Coverage
Corporate Governance
Financials & Filings
- SEC Filings
IR Resources

News Releases

Breadcrumb

Home /
Investor Relations /
News & Events /
News Releases

Year

12 May 2017

Abbas Hussain Joins the Board of Immunocore as Non-Executive Director

8 May 2017

Immunocore identifies second novel ImmTAC® in the GSK collaboration

5 April 2017

Immunocore Publishes Gender Pay Report

28 February 2017

Immunocore to Present at the Cowen and Company 37th Annual Healthcare Conference

1 December 2016

Immunocore wins Financing Deal of the Year at the 12th Annual SCRIP Awards 2016

9 November 2016

Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress

12 October 2016

Immunocore Appoints Paul Fry as Chief Financial Officer

12 September 2016

Immunocore Ranked in the Sunday Times Hiscox Tech Track 100

7 September 2016

Immunocore Wins Private UK Life Science Company of the Year at Biotech and Money Assembly and Awards.

8 June 2016

Immunocore’s ImmTAV shown to redirect the immune system to kill HIV-infected cells from patients treated with antiretroviral therapy

Pagination

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Displaying 61 - 70 of 122

Site - Shareholder Tools

Immunocore

Site - Footer Social

About us
Our science
Our therapy areas
For patients

News
Careers
Contact us

Privacy and Social Media Guidelines
Cookies
Payments and Disclosures
Clinical trials

©2021 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd